The cross-talk between signaling pathways, noncoding RNAs and DNA damage response: Emerging players in cancer progression
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Molecular Biology,Biochemistry
Reference117 articles.
1. DNA repair dysregulation from cancer driver to therapeutic target;Curtin;Nat. Rev. Cancer,2012
2. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project;Birney;Nature,2007
3. Distinct phosphatases antagonize the p53 response in different phases of the cell cycle;Shaltiel;Proc. Natl. Acad. Sci. U. S. A.,2014
4. DNA repair and damage pathways in breast cancer development and therapy;Majidinia;DNA Repair,2017
5. ATM in DNA repair in cancer;Jin;Pharmacol. Ther.,2019
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. MicroRNA dysregulation in ataxia telangiectasia;Frontiers in Immunology;2024-08-19
2. Advances in the mechanism of small nucleolar RNA and its role in DNA damage response;Military Medical Research;2024-08-08
3. Targeting DNA Damage Response Deficiency in Thoracic Cancers;Drugs;2024-07-13
4. Exploring the role of lncrna neat1 knockdown in regulating apoptosis across multiple cancer types: A review;Pathology - Research and Practice;2023-12
5. Applications of engineered exosomes in drugging noncoding RNAs for cancer therapy;Chemical Biology & Drug Design;2023-07-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3